Latest filing published 20 Dec 2006 for JAVELIN PHARMACEUTICALS, INC, €14k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark Matthews: trading record in brief
Mark Matthews appears in our data through filings on Javelin Pharmaceuticals, Inc shares, published by SEC (Form 4). Between 27 November 2006 and 18 December 2006, the trades on record add up to 5 filings.
Purchases make up the whole of the open-market record (5 purchases, €54k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
A typical purchase (the median) is worth €12k.
The latest filing, published on 20 December 2006, reports an open-market purchase of €14k in Javelin Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark Matthews
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$3.85Common Stock, $.001 par valueSEC:0000950120-06-000789:0Canonical exit: 5 Mar 2007 (T+90)
- 3,500 shares@ US$4.45Common Stock, $.001 par valueSEC:0000950120-06-000789:1Canonical exit: 18 Mar 2007 (T+90)
- 5,000 shares@ US$3.85Common Stock, $.001 par valueSEC:0000950120-06-000761:0Canonical exit: 4 Mar 2007 (T+90)
- 2,500 shares@ US$3.44Common Stock, $.001 par valueSEC:0000950120-06-000752:0Canonical exit: 25 Feb 2007 (T+90)
- 2,500 shares@ US$3.40Common Stock, $.001 par valueSEC:0000950120-06-000752:1Canonical exit: 25 Feb 2007 (T+90)
5 of 5 declarations